SynthesisThe Cochrane database of systematic reviews2009
Healthcare financing systems for increasing the use of tobacco dependence treatment.
Synthesis in The Cochrane database of systematic reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Healthcare financing systems for increasing the use of tobacco dependence treatment.The Cochrane database of systematic reviews · 2017Pooled it
- Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.The Cochrane database of systematic reviews · 2014Pooled it
- Urologist-led smoking cessation: a way forward through implementation science.Translational andrology and urology · 2021Article
- A reporting framework for describing and a typology for categorizing and analyzing the designs of health care pay for performance schemes.BMC health services research · 2018Article
- German Public Support for Tobacco Control Policy Measures: Results from the German Study on Tobacco Use (DEBRA), a Representative National Survey.International journal of environmental research and public health · 2018Article
- Public Health Policy in Support of Insurance Coverage for Smoking Cessation Treatments.Healthcare policy = Politiques de sante · 2017Article
- Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers.Advances in therapy · 2017Article
- Costs of the Smoking Cessation Program in Brazil.Revista de saude publica · 2016Article
- Online Tobacco Cessation Training and Competency Assessment for Complementary and Alternative Medicine (CAM) Practitioners: Protocol for the CAM Reach Web Study.JMIR research protocols · 2016Article
- Delivering evidence-based smoking cessation treatment in primary care practice: experience of Ontario family health teams.Canadian family physician Medecin de famille canadien · 2014Observational
- Expansion of Medicaid covered smoking cessation services: maternal smoking and birth outcomes.Medicare & medicaid research review · 2013Article
- Self-reported exposure to policy and environmental influences on smoking cessation and relapse: a 2-year longitudinal population-based study.International journal of environmental research and public health · 2011Article
- Treatment of tobacco dependence.Deutsches Arzteblatt international · 2011Review
- Article
- Governments, pay for smoking cessation.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2010Article
- Clinical management of smoking cessation: patient factors affecting a reward-based approach.Patient preference and adherence · 2010Article
- Quit smoking advice from health professionals in Taiwan: the role of funding policy and smoker socioeconomic status.Tobacco control · 2010Article
- Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.PharmacoEconomics · 2010Review
- Interest in treatments to stop smoking.Journal of substance abuse treatment · 2009Article
Corrections and comments
- Updated by
- Update of
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe hypothesized that provision of financial assistance for smokers trying to quit, or reimbursement of their care providers, could lead to an increased rate of successful quit attempts.
objectivesThe primary objective of this review was to assess the impact of reducing the costs of providing or using smoking cessation treatment by health care financing interventions on abstinence from smoking and utilization of smoking cessation treatment. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction group specialized register; the Cochrane Central Register of Controlled Trials (CENTRAL) Issue 3, 2008; MEDLINE (from January 1966 to August 2008) and EMBASE (from January 1980 to August 2008) to identify trials. SELECTION CRITERIA: We included randomized controlled trials (RCTs) and controlled trials involving financial benefit interventions to smokers or their health care providers or both. DATA COLLECTION AND ANALYSIS: Three reviewers independently extracted data and assessed the quality of the included studies. Rate ratios (RR) were calculated for individual studies on an intention-to-treat basis and meta-analysis was performed using a random effects model. We included economic evaluations when a study presented the costs and effects of two or more alternatives. MAIN
resultsWe found nine trials involving financial interventions directed at smokers and two studies directed at health care providers.There was a statistically significant favourable effect of full financial interventions directed at smokers on continuous abstinence compared to no interventions with a risk ratio (RR) of 4.38 (95% CI 1.94 to 9.87). There was also a significant effect of full financial interventions when compared to no interventions on the number of participants making a quit attempt (RR 1.19; 95% CI 1.07 to 1.32; N = 3). There was a significant effect of financial interventions directed at health care providers in increasing the utilization of behavioural interventions for smoking cessation (RR 1.33; 95% CI 1.01 to 1.77). Comparison of full benefit with partial or no benefit resulted in costs per additional quitter ranging from $260 to $1453. AUTHORS'
conclusionsFull financial interventions directed at smokers when compared to no financial interventions could increase the proportion quitting, quit attempts and utilization of pharmacotherapy by smokers. Although the absolute differences were small the costs per additional quitter were low. The methodological qualities of the included studies need to be taken into consideration in interpreting the conclusions.
Indexed as
Identifiers
19370599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.